Hemetron offers a handheld blood testing device that measures biomarkers for at‑home health monitoring and remote result sharing.
Hemetron's investors include Innosuisse.
Hemetron is headquartered in Zürich, Switzerland.
Hemetron offers a handheld blood testing device that measures biomarkers for at‑home health monitoring and remote result sharing.
Hemetron is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hemetron — Funding & Investors." VCBacked, September 1, 2025, https://www.vcbacked.co/company/hemetron. Accessed August 14, 2026.
VCBacked. (2025). Hemetron — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/hemetron
{{cite web |title=Hemetron — Funding & Investors |url=https://www.vcbacked.co/company/hemetron |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated